You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
個股熱度排行 | 6月21日港股收盤
根據uSMART輿情監測數據,21日港股交易時段,市場關注指數最高的5只股票是騰訊控股、新東方在線、匯豐控股、信達生物、阿裏健康。6月21日—港股關注排行TOP5 騰訊控股 關注度第一爲騰訊控股,該股今日收盤上漲2.75%,報於381.00港元。近5個交易日累計上漲1.33%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有: 巨頭縱身元宇宙:騰訊“攤牌” Meta“炫技” 蘋果AR“猶抱琵琶” 馬化騰曾預言一場大洗牌即將開始 騰訊成立XR業務線欲“上船” 新東方在線 關注度第二爲新東方在線,該股今日收盤上漲3.06%,報於17.50港元。近5個交易日累計上漲62.94%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有: 各路資金清倉後,新東方在線迎來反彈,目前漲超7% 盤中漲超16倍!超越上週新東方在線表現 港股資金日趨瘋狂 匯豐控股 關注度第三爲匯豐控股,該股今日收盤上漲3.73%,報於51.40港元。近5個交易日累計上漲3.73%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有: 匯豐控股6月20日註銷160萬股 匯豐控股漲3.23% 昨日合共回購逾276萬股 信達生物 關注度第四爲信達生物,該股今日收盤上漲13.54%,報於30.60港元。近5個交易日累計上漲15.47%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有: 信達生物漲近4% PD-1抑制劑上市申請已獲批準 醫藥股受捧 新藥上市獲批信達生物急漲15% 阿裏健康 關注度第五爲阿裏健康,該股今日收盤上漲12.10%,報於5.56港元。近5個交易日累計上漲17.30%。在消息面和社交媒體方面,輿情以看多爲主。較被市場關注的消息有: 恆生指數午間收漲1.43%報21466點 互聯網醫療股走高 阿裏健康漲10.28% 港股午評:港股高開高走 阿裏健康大漲10% 中電控股跌近6%
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account